Signal Transduction and Targeted Therapy
Nature Publishing Group
About the journal
Signal Transduction and Targeted Therapy is an open-access journal published by Nature Publishing Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,090 GBP. Declared review time at DOAJ: 5 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Nature Publishing Group
- ISSN
- 2095-9907 · 2059-3635
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,090 GBP
- Articles in DOAJ
- 2482
- Declared review time
- 5 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/sigtrans/
Index listings
- DOAJ · 2016-11-29
- MEDLINE · 2020-01-01
- PUBMED · 2020-01-03
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,090 GBP
- Declared review time (DOAJ)
- 5 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
2482
Most recent article
last month
Average review time (journal-declared via DOAJ)
5weeks
Works in OpenAlex
2828
Last recorded publication year
2026
h-index
271
i10-index
1800
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2016-11-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 85%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Xinhao zhuandao yu baxiang zhiliao
- Source type
- journal
- NLM unique ID (PubMed)
- 101676423
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- RNA modifications and cancer
- RNA modifications and cancer
Show all subjects (50)
- Immune Cell Function and Interaction
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- CAR-T cell therapy research
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Immune cells in cancer
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Cancer, Hypoxia, and Metabolism
- Immunotherapy and Immune Responses
- Cancer, Hypoxia, and Metabolism
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- interferon and immune responses
- interferon and immune responses
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer-related gene regulation
- Long-Term Effects of COVID-19
- Long-Term Effects of COVID-19
- MicroRNA in disease regulation
- Cancer-related gene regulation
- CRISPR and Genetic Engineering
- MicroRNA in disease regulation
- Phagocytosis and Immune Regulation
- Phagocytosis and Immune Regulation
- CRISPR and Genetic Engineering
- Extracellular vesicles in disease
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Extracellular vesicles in disease
- T-cell and B-cell Immunology
- RNA Research and Splicing
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- T-cell and B-cell Immunology
- RNA Research and Splicing
Keywords (DOAJ)
- molecular biology
- cell biology
- pharmacology
- medicinal chemistry
- computational chemistry
- systems biology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ